Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

COVID-19 Latest Developments – New Results from Vaccine Studies, Dexamethasone, Symptom Tracking App, New Diagnostic Test, Rising Stillbirth Rates

COVID-19 Latest Developments – New Results from Vaccine Studies, Dexamethasone, Symptom Tracking App, New Diagnostic Test, Rising Stillbirth Rates

The scientific community's work on the novel coronavirus (SARS-CoV-2) and the resulting COVID-19 disease is continuing at full speed to develop treatments. For this purpose, different approaches are being tested to generate an immune response against SARS-CoV-2. Let us look at the latest developments in this field together.

New data from vaccine studies

Early-stage results for two experimental SARS-CoV-2 vaccines under development, from clinical trials, show that the vaccines stimulate an immune system response and are safe enough for the trials to continue.

The vaccine developed by scientists conducting research at Oxford University is a vaccine that uses a weakened form of an adenovirus (ChAdOx1) that causes upper respiratory tract infections. With its genetic characteristics modified, it causes infection in chimpanzees but does not show the ability to grow in the human body. The genetic code needed to produce the S protein, which is displayed on the surface of the SARS-CoV-2 coronavirus and plays an important role in causing infection, has also been added to this virus used for the vaccine. The aim is for immune system cells to recognize the S protein and generate an immune response, thereby preventing the virus from entering cells and causing infection. In phase 1 and phase 2 clinical trials conducted by Oxford University, people who received the vaccine showed a T cell response that peaked 14 days after vaccination and an antibody response after 28 days. Sarah Gilbert, a professor of vaccinology at Oxford University and the head of the vaccine development team, described the challenge they faced during this process by saying, "The main problem faced by scientists trying to develop a vaccine against a particular virus is not knowing how strong the immune response needs to be". Another vaccine developed by CanSino Biologics and China's military research unit was also reported to trigger an immune response in patients participating in clinical trials and to be safe for use. 

- Related topic: The VACCINE RACE against coronavirus – an illustrated guide

Results of dexamethasone (a type of cortisone) treatment

Dexamethasone, a corticosteroid (cortisone), is used in many different conditions, from rheumatic diseases to organ transplantation and cancer, thanks to its anti-inflammatory and immunosuppressive (immune-suppressing) effects. Dexamethasone tested in hospitalized patients diagnosed with COVID-19 in the United Kingdom was found to benefit "critically ill" patients.

Initial findings shared with the World Health Organization (WHO) reported that dexamethasone use reduced deaths by one-third in patients on ventilators. The full results of the study demonstrate that dexamethasone clearly works in patients with severe signs and symptoms who need respiratory support. Following these data, Dr. Peter Horby, who leads the clinical trials, states that dexamethasone should be used as a standard treatment in patients diagnosed with COVID-19. However, it is worth remembering that dexamethasone has not currently been approved by any country's health authority as a treatment specific to COVID-19, and that this potential benefit has only been tested for the treatment of patients in intensive care.

A symptom tracking app may help with the right treatment

King's College London collected and analyzed data from a mobile app that tracks COVID-19 symptoms. Researchers identified 6 different groups of COVID-19 symptoms. The study, published as a preprint, associates the symptom groups with the severity of infection and hospitalization, as well as the likelihood of needing oxygen or mechanical ventilation (a ventilator). Scientists state that these symptom groups can help doctors identify which patients are at the greatest risk and, during the pandemic's potential future waves, determine which patients will need inpatient hospital treatment.

The 6 symptom groups identified in the study were as follows:

  • Group 1: Mainly upper respiratory tract symptoms, such as a persistent cough and muscle pain. In this group, 1.5% needed respiratory support, and 16% went to hospital at least once. This was the most common symptom group. 
  • Group 2: Upper respiratory tract symptoms that occurred more frequently than in Group 1, including fever and skipping meals. In this group, 4.4% of patients needed a ventilator, and 17.5% went to hospital at least once.
  • Group 3: Predominantly gastrointestinal symptoms, such as diarrhea. In this group, 3.7% of patients later needed respiratory support. Approximately 24% of patients went to hospital.
  • Group 4: Severe fatigue, persistent chest pain and cough. In this group, 8.6% needed respiratory support, and 23.6% went to hospital at least once. 
  • Group 5: Confusion, skipping meals and severe fatigue. In this group, 9.9% of patients needed respiratory support. In this group, 24.6% of patients went to hospital. 
  • Group 6: Confusion, fatigue and gastrointestinal problems, as well as shortness of breath and chest pain. Approximately 20% of patients in this group received respiratory support, and 45.5% went to hospital. This was the least common of the groups.
covid 19 symptoms by frequency

Results are obtained more quickly with a new diagnostic method

The United States Food and Drug Administration (FDA) issued an emergency use authorization (EUA) over the weekend for the use of pooled samples in COVID-19 diagnostic testing. The EUA allows the 'Quest Polymerase Chain Reaction (PCR)' test to work with samples taken from up to four people rather than testing each sample separately. FDA official Stephen Hahn summarized the importance of the new decision in a press statement, saying, "Sample pooling provides a very important advantage. With this method, samples from 4 individuals can be analyzed at once. This allows more COVID-19 diagnostic tests to be performed more quickly while conserving testing supplies". If a test conducted using samples from four people is positive, each sample is tested separately to identify the COVID-19-positive patient. On the other hand, most test results are expected to be negative, particularly in areas where the outbreak is less widespread. This method offers the advantage of obtaining results in a very short time.

- Related topic: How is coronavirus testing performed? What are PCR and rapid diagnostic test types?

The stillbirth rate is rising

According to a study of pregnancy outcomes at St. George's University Hospital in London, stillbirth rates have increased since the start of the COVID-19 Pandemic. A scientist involved in the study commented on the situation as follows: "The increase in stillbirths may have resulted from indirect effects such as reluctance to attend hospital in situations such as reduced fetal movements, fear of contracting an infection, or not wanting to place an additional burden on the National Health Service, whose workload increased during the pandemic".

It is therefore extremely important to stay in contact with a specialist physician throughout pregnancy and attend examinations when necessary.

Conclusion

Scientists continue their work to bring the novel coronavirus, which affects many areas of life, to a conclusion worldwide as soon as possible. We will continue to share the new information we learn in this field every day. During this period, remember that you can protect yourself and your loved ones by paying particular attention to hand hygiene, maintaining social distancing and taking care to wear a mask outside the home. 

*

- Related topic: COVID-19 Latest Developments – New Treatment Protocol, Lower Death Rate, Unexpected Viral Load, No Benefit from Early Plaquenil Use 

*

- ALL OUR CORONAVIRUS ARTICLES 

*

Sources

COVID-19 Update: New Data on Vaccines, Dexamethasone Results - Medscape - Jul 20, 2020.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

COVID-19 Latest Developments – New Results from Vaccine Studies, Dexamethasone, Symptom Tracking App, New Diagnostic Test, Rising Stillbirth Rates

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy